Clinical trial
A Study of Sertraline to Prevent PTSD
NCT00182078 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00182078 |
|---|---|
| Title | A Study of Sertraline to Prevent PTSD |
| Official title | A Study of Sertraline to Prevent PTSD |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Posttraumatic Stress Disorder, Depression |
| Intervention type | Drug |
| Interventions | Placebo, Sertraline |
| Enrollment | 26 |
| Start date | Nov 1, 2002 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Aug 5, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: